124 related articles for article (PubMed ID: 15922936)
1. Combinatorial biomarkers: From early toxicology assays to patient population profiling.
Koop R
Drug Discov Today; 2005 Jun; 10(11):781-8. PubMed ID: 15922936
[TBL] [Abstract][Full Text] [Related]
2. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
Phan JH; Quo CF; Wang MD
Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of human populations for early markers of cadmium toxicity: a review.
Fowler BA
Toxicol Appl Pharmacol; 2009 Aug; 238(3):294-300. PubMed ID: 19433102
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Metabonomic modeling of drug toxicity.
Keun HC
Pharmacol Ther; 2006 Jan; 109(1-2):92-106. PubMed ID: 16051371
[TBL] [Abstract][Full Text] [Related]
6. Novel biomarkers of acute kidney toxicity.
Goodsaid FM; Blank M; Dieterle F; Harlow P; Hausner E; Sistare F; Thompson A; Vonderscher J
Clin Pharmacol Ther; 2009 Nov; 86(5):490-6. PubMed ID: 19710639
[TBL] [Abstract][Full Text] [Related]
7. New technologies and screening strategies for hepatotoxicity: use of in vitro models.
Dambach DM; Andrews BA; Moulin F
Toxicol Pathol; 2005; 33(1):17-26. PubMed ID: 15805052
[TBL] [Abstract][Full Text] [Related]
8. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
[TBL] [Abstract][Full Text] [Related]
10. In biomarkers we trust?
Baker M
Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081
[No Abstract] [Full Text] [Related]
11. Identification of in vitro protein biomarkers of idiosyncratic liver toxicity.
Gao J; Ann Garulacan L; Storm SM; Hefta SA; Opiteck GJ; Lin JH; Moulin F; Dambach DM
Toxicol In Vitro; 2004 Aug; 18(4):533-41. PubMed ID: 15130611
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of sepsis.
Marshall JC; Reinhart K;
Crit Care Med; 2009 Jul; 37(7):2290-8. PubMed ID: 19487943
[TBL] [Abstract][Full Text] [Related]
13. The application of genomic and proteomic technologies in predictive, preventive and personalized medicine.
Collins CD; Purohit S; Podolsky RH; Zhao HS; Schatz D; Eckenrode SE; Yang P; Hopkins D; Muir A; Hoffman M; McIndoe RA; Rewers M; She JX
Vascul Pharmacol; 2006 Nov; 45(5):258-67. PubMed ID: 17030152
[TBL] [Abstract][Full Text] [Related]
14. Artificial neural network technologies to identify biomarkers for therapeutic intervention.
Bicciato S
Curr Opin Mol Ther; 2004 Dec; 6(6):616-23. PubMed ID: 15663326
[TBL] [Abstract][Full Text] [Related]
15. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
16. Molecular biomarkers in drug development.
Lewin DA; Weiner MP
Drug Discov Today; 2004 Nov; 9(22):976-83. PubMed ID: 15539141
[TBL] [Abstract][Full Text] [Related]
17. Metabonomics: systems biology in pharmaceutical research and development.
Lindon JC; Holmes E; Nicholson JK
Curr Opin Mol Ther; 2004 Jun; 6(3):265-72. PubMed ID: 15264428
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers in aquatic plants: selection and utility.
Brain RA; Cedergreen N
Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039
[TBL] [Abstract][Full Text] [Related]
19. Creation of a digital slide and tissue microarray resource from a multi-institutional predictive toxicology study in the rat: an initial report from the PredTox group.
Mulrane L; Rexhepaj E; Smart V; Callanan JJ; Orhan D; Eldem T; Mally A; Schroeder S; Meyer K; Wendt M; O'Shea D; Gallagher WM
Exp Toxicol Pathol; 2008 Aug; 60(4-5):235-45. PubMed ID: 18479893
[TBL] [Abstract][Full Text] [Related]
20. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
